Scant drug ingredients linked to US generic-drug shortages in first 2 COVID years
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 In the first 2 years of the COVID-19 pandemic, shortages of 11% of generic active pharmaceutical ingredients (APIs) made by global manufacturers—35% of them from larger facilities in India—were tied to generic-drug unavailability in the United States, according to a research letter posted this week in JAMA. Johns Hopkins University researchers analyzed US drug shortage data from the Food and Drug Administration (FDA) from January 2020 to